Skip to Content

Join the 'Sterapred DS' group to help and get support from people like you.

Sterapred DS Support Group


Our support group for Sterapred DS has 1 questions and 3 members. Updated 23 Sep 2010.

Further Information

Related Condition Support Groups

Sinusitis, Allergic Reactions, Rheumatoid Arthritis, Asthma, Systemic Lupus Erythematosus, Idiopathic (Immune) Thrombocytopenic Purpura, Inflammatory Conditions, Fibromyalgia, Adrenocortical Insufficiency, view more... Inflammatory Bowel Disease, Acute Lymphocytic Leukemia, Multiple Sclerosis, Ulcerative Colitis, Sarcoidosis, Contact Dermatitis, Atopic Dermatitis, Osteoarthritis, Dermatomyositis, Psoriasis, Ankylosing Spondylitis, Psoriatic Arthritis, Adrenogenital Syndrome, Skin Rash, Nephrotic Syndrome, Pharyngitis, Aspiration Pneumonia, Gouty Arthritis, Herpes Zoster Otitis Externa, Lymphoma, Neurosarcoidosis, Hay Fever, Allergic Rhinitis, Scleroderma, Mixed Connective Tissue Disease, Lichen Sclerosus, Herpes Zoster, Synovitis, Cluster Headaches, Corneal Ulcer, Conjunctivitis - Allergic, Autoimmune Hemolytic Anemia, Eczema, Hypercalcemia of Malignancy, Immunosuppression, Herpes Zoster Iridocyclitis, Leukemia, Bursitis, Uveitis (Posterior), Tuberculous Meningitis, Thrombocytopenia, Lichen Planus, Systemic Sclerosis, Seborrheic Dermatitis, Tuberculosis - Extrapulmonary, Toxic Epidermal Necrolysis, Iritis, Polymyositis / Dermatomyositis, Cogan's Syndrome, Erythroblastopenia, Bullous Pemphigoid, Loeffler's Syndrome, Pemphigus, Berylliosis, Mycosis Fungoides, Dermatitis Herpetiformis, Chorioretinitis, Iridocyclitis, Pemphigoid, Keratitis, Juvenile Rheumatoid Arthritis, Graft-versus-host disease, Epicondylitis - Tennis Elbow

Sterapred DS Patient Information at

Latest News

Immune-Based Drug May Ease Chronic Eye Condition

WEDNESDAY, Sept. 7, 2016 – People with chronic eye inflammation known as uveitis may be able to keep the condition at bay with the immune-suppressing drug Humira (adalimumab), a new study ...

Read more news...

Latest Questions

Ask a Question